Drugs / Melan-A vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00324623 | Sep 2005 → Nov 2011 | cutaneous melanoma | Prof. Serge Leyvraz | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Melan-A vaccine | “Patients also receive vaccination comprising Melan-A vaccine emulsified in incomplete Freund's adjuvant (IFA) subcutaneously (SC) once every 3 weeks beginning on day 0.” NCT00324623 ↗ |
| Route | Subcutaneous | “Melan-A vaccine emulsified in incomplete Freund's adjuvant (IFA) subcutaneously (SC)” NCT00324623 ↗ |